Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 29% ± 4% | |
glutamatergic neuron | 3 studies | 36% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 356.38 | 653 / 653 | 100% | 8.32 | 603 / 605 |
liver | 100% | 315.04 | 225 / 226 | 100% | 7.10 | 406 / 406 |
kidney | 100% | 426.60 | 89 / 89 | 100% | 8.47 | 897 / 901 |
intestine | 100% | 398.51 | 966 / 966 | 99% | 11.25 | 524 / 527 |
breast | 100% | 238.68 | 458 / 459 | 100% | 9.84 | 1114 / 1118 |
brain | 99% | 350.86 | 2622 / 2642 | 100% | 8.13 | 705 / 705 |
bladder | 100% | 232.57 | 21 / 21 | 99% | 9.83 | 500 / 504 |
esophagus | 100% | 251.09 | 1439 / 1445 | 99% | 7.31 | 182 / 183 |
stomach | 100% | 349.58 | 359 / 359 | 99% | 9.59 | 283 / 286 |
adrenal gland | 100% | 525.90 | 258 / 258 | 99% | 9.46 | 227 / 230 |
uterus | 99% | 216.19 | 168 / 170 | 100% | 9.19 | 457 / 459 |
skin | 100% | 303.98 | 1802 / 1809 | 98% | 7.80 | 464 / 472 |
prostate | 100% | 229.11 | 244 / 245 | 98% | 5.45 | 493 / 502 |
pancreas | 95% | 141.78 | 313 / 328 | 99% | 7.00 | 177 / 178 |
lung | 89% | 176.88 | 512 / 578 | 99% | 8.34 | 1149 / 1155 |
ovary | 96% | 174.93 | 173 / 180 | 90% | 4.39 | 387 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.31 | 29 / 29 |
spleen | 100% | 335.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.89 | 1 / 1 |
muscle | 100% | 671.61 | 802 / 803 | 0% | 0 | 0 / 0 |
adipose | 99% | 202.87 | 1186 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 174.05 | 1303 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 626.01 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 5.02 | 72 / 80 |
peripheral blood | 64% | 185.84 | 590 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007399 | Biological process | nervous system development |
GO_0006744 | Biological process | ubiquinone biosynthetic process |
GO_0050773 | Biological process | regulation of dendrite development |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0008753 | Molecular function | NADPH dehydrogenase (quinone) activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | RTN4IP1 |
Protein name | Reticulon 4 interacting protein 1 Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein) |
Synonyms | NIMP |
Description | FUNCTION: Plays a role in the regulation of retinal ganglion cell (RGC) neurite outgrowth, and hence in the development of the inner retina and optic nerve. Appears to be a potent inhibitor of regeneration following spinal cord injury. . |
Accessions | ENST00000539449.2 ENST00000369063.8 [Q8WWV3-1] Q8WWV3 G3V1R2 |